Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients.
Emanuele La CorteMichele Dei CasAlberto RaggiMonica PatanèMorgan BroggiSilvia SchiavolinChiara CalatozzoloBianca PolloCarlotta PipoloMaria Grazia BruzzoneGiuseppe CampisiRita ParoniRiccardo GhidoniPaolo FerroliPublished in: International journal of molecular sciences (2019)
Our lipid analysis showed ceramides to be promising tumoral biomarkers in skull base chordomas. Long- and very-long-chain ceramides, such as Cer C24:1 and DHCer C24:1, may be related to a prolonged tumor survival and aggressiveness, and the understanding of their effective biological role will hopefully shed light on the mechanisms of chordoma radio-resistance, tendency to recur, and use of agents targeting ceramide metabolism.